Association of Chronic Kidney Disease With the Spectrum of Ankle Brachial Index. The CHS (Cardiovascular Health Study)

Journal of the American College of Cardiology

Volumn 54, Issue 13, 2009, Pages 1176-1184

  Ix, Joachim H ^a,b,c   Katz, Ronit ^d   De Boer, Ian H ^e,f   Kestenbaum, Brian R ^e   Allison, Matthew A ^b   Siscovick, David S ^d   Newman, Anne B ^g   Sarnak, Mark J ^h   Shlipak, Michael G ^i,j   Criqui, Michael H ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^g UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^h TUFTS MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

arterial stiffness; atherosclerosis; calcium; cardiovascular disease; chronic; kidney disease

Indexed keywords

C REACTIVE PROTEIN; CREATININE; CYSTATIN C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COMMUNITY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE; SMOKING;

AGED; AGED, 80 AND OVER; ANKLE BRACHIAL INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; LIPIDS; MALE; RISK FACTORS;

EID: 70049117207     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.06.017     Document Type: Article

References (61)

1. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 298 (2007) 2038-2047
2. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
3. Shlipak M.G., Katz R., Sarnak M.J., et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly people without chronic kidney disease. Ann Intern Med 145 (2006) 237-246
4. Keith D.S., Nichols G.A., Gullion C.M., Brown J.B., and Smith D.H. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164 (2004) 659-663
5. Feldman H.I., Appel L.J., Chertow G.M., et al. The Chronic Renal Insufficiency Cohort (CRIC) study: design and methods. J Am Soc Nephrol 14 (2003) S148-S153
6. Braun J., Oldendorf M., Moshage W., Heidler R., Zeitler E., and Luft F.C. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27 (1996) 394-401
7. Goodman W.G., Goldin J., Kuizon B.D., et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342 (2000) 1478-1483
8. Flegal K.M., Carroll M.D., Ogden C.L., and Johnson C.L. Prevalence and trends in obesity among U.S. adults, 1999-2000. JAMA 288 (2002) 1723-1727
9. Raggi P., Bellasi A., Ferramosca E., Islam T., Muntner P., and Block G.A. Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients. Kidney Int 71 (2007) 802-807
10. Matsuoka M., Iseki K., Tamashiro M., et al. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 8 (2004) 54-58
11. London G.M., Marchais S.J., Guerin A.P., Metivier F., and Adda H. Arterial structure and function in end-stage renal disease. Nephrol Dial Transplant 17 (2002) 1713-1724
12. Monckeberg J. Uber die reine mediaverkalkung der extremitatenarterien und ihr verhalten zur arteriosklerose. Virchows Arch Pathol Anat 171 (1902) 141-167
13. London G.M., Guerin A.P., Marchais S.J., Metivier F., Pannier B., and Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18 (2003) 1731-1740
14. Dao H.H., Essalihi R., Bouvet C., and Moreau P. Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension. Cardiovasc Res 66 (2005) 307-317
15. Ouriel K., and Zarins C.K. Doppler ankle pressure: an evaluation of three methods of expression. Arch Surg 117 (1982) 1297-1300
16. Yao S.T., Hobbs J.T., and Irvine W.T. Ankle systolic pressure measurements in arterial disease affecting the lower extremities. Br J Surg 56 (1969) 676-679
17. Leng G.C., Lee A.J., Fowkes F.G., et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 25 (1996) 1172-1181
18. McDermott M.M., Feinglass J., Slavensky R., and Pearce W.H. The ankle-brachial index as a predictor of survival in patients with peripheral vascular disease. J Gen Intern Med 9 (1994) 445-449
19. McKenna M., Wolfson S., and Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 87 (1991) 119-128
20. Newman A.B., Shemanski L., Manolio T.A., et al., Cardiovascular Health Study Group. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 19 (1999) 538-545
21. Newman A.B., Tyrrell K.S., and Kuller L.H. Mortality over four years in SHEP participants with a low ankle-arm index. J Am Geriatr Soc 45 (1997) 1472-1478
22. Vogt M.T., McKenna M., Anderson S.J., Wolfson S.K., and Kuller L.H. The relationship between ankle-arm index and mortality in older men and women. J Am Geriatr Soc 41 (1993) 523-530
23. Fowkes F.G., Murray G.D., Butcher I., et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 300 (2008) 197-208
24. Hiatt W.R. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 344 (2001) 1608-1621
25. Orchard T.J., and Strandness Jr. D.E. Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association, September 18-20, 1992, New Orleans, Louisiana. Circulation 88 (1993) 819-828
26. Young M.J., Adams J.E., Anderson G.F., Boulton A.J., and Cavanagh P.R. Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia 36 (1993) 615-621
27. O'Hare A.M., Katz R., Shlipak M.G., Cushman M., and Newman A.B. Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation 113 (2006) 388-393
28. Resnick H.E., Lindsay R.S., McDermott M.M., et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 109 (2004) 733-739
29. Sutton-Tyrrell K., Venkitachalam L., Kanaya A.M., et al. Relationship of ankle blood pressures to cardiovascular events in older adults. Stroke 39 (2008) 863-869
30. O'Hare A.M., Glidden D.V., Fox C.S., and Hsu C.Y. High prevalence of peripheral arterial disease in people with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation 109 (2004) 320-323
31. O'Hare A.M., Vittinghoff E., Hsia J., and Shlipak M.G. Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the Heart and Estrogen/Progestin Replacement Study (HERS). J Am Soc Nephrol 15 (2004) 1046-1051
32. Shlipak M.G., Fried L.F., Crump C., et al. Cardiovascular disease risk status in elderly people with renal insufficiency. Kidney Int 62 (2002) 997-1004
33. Wattanakit K., Folsom A.R., Selvin E., Coresh J., Hirsch A.T., and Weatherley B.D. Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) study. J Am Soc Nephrol 18 (2007) 629-636
34. Fried L.P., Borhani N.O., Enright P., et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1 (1991) 263-276
35. Tell G.S., Fried L.P., Hermanson B., Manolio T.A., Newman A.B., and Borhani N.O. Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol 3 (1993) 358-366
36. Erlandsen E.J., Randers E., and Kristensen J.H. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest 59 (1999) 1-8
37. Stevens L.A., Coresh J., Schmid C.H., et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 51 (2008) 395-406
38. Shlipak M.G., Fried L.F., Cushman M., et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 293 (2005) 1737-1745
39. Levey A.S., Greene T., Kusek J.W., and Beck G.J. A simplified equation to predict glomerular filtration rate from serum creatinine (abstr). J Am Soc Nephrol 11 (2001) A0828
40. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2002) S1-S266
41. Tell G.S., Rutan G.H., Kronmal R.A., et al., Cardiovascular Health Study (CHS) Collaborative Research Group. Correlates of blood pressure in community-dwelling older adults. The Cardiovascular Health Study. Hypertension 23 (1994) 59-67
42. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
43. Barzilay J.I., Abraham L., Heckbert S.R., et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 50 (2001) 2384-2389
44. Macy E.M., Hayes T.E., and Tracy R.P. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 43 (1997) 52-58
45. Sidak Z. Rectangular confidence regions for the means of multivariate normal distributions. J Am Stat Assoc 62 (1967) 626-633
46. Ix J.H., Chertow G.M., Shlipak M.G., Brandenburg V.M., Ketteler M., and Whooley M.A. Association of fetuin-A with mitral annular calcification and aortic stenosis among people with coronary heart disease: data from the Heart and Soul Study. Circulation 115 (2007) 2533-2539
47. Kramer H., Toto R., Peshock R., Cooper R., and Victor R. Association between chronic kidney disease and coronary artery calcification: the Dallas Heart Study. J Am Soc Nephrol 16 (2005) 507-513
48. Essalihi R., Dao H.H., Yamaguchi N., and Moreau P. A new model of isolated systolic hypertension induced by chronic warfarin and vitamin K1 treatment. Am J Hypertens 16 (2003) 103-110
49. Niederhoffer N., Lartaud-Idjouadiene I., Giummelly P., Duvivier C., Peslin R., and Atkinson J. Calcification of medial elastic fibers and aortic elasticity. Hypertension 29 (1997) 999-1006
50. Ix J.H., Katz R., Kestenbaum B., et al. Association of mild to moderate kidney dysfunction and coronary calcification. J Am Soc Nephrol 19 (2008) 579-585
51. Gross M.L., Meyer H.P., Ziebart H., et al. Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients. Clin J Am Soc Nephrol 2 (2007) 121-134
52. Shlipak M.G., Sarnak M.J., Katz R., et al. Cystatin C and the risk of death and cardiovascular events among elderly people. N Engl J Med 352 (2005) 2049-2060
53. Suominen V., Rantanen T., Venermo M., Saarinen J., and Salenius J. Prevalence and risk factors of PAD among patients with elevated ABI. Eur J Vasc Endovasc Surg 35 (2008) 709-714
54. Aboyans V., Ho E., Denenberg J.O., Ho L.A., Natarajan L., and Criqui M.H. The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects. J Vasc Surg 48 (2008) 1197-1203
55. de Vinuesa S.G., Ortega M., Martinez P., Goicoechea M., Campdera F.G., and Luno J. Subclinical peripheral arterial disease in patients with chronic kidney disease: prevalence and related risk factors. Kidney Int Suppl (2005) S44-S47
56. Sigurdsson G., Duprez D.A., Hirsch A.T., Florea N., Hoke L., and Cohn J.N. Supranormal ankle brachial index is associated with favorable exercise blood pressure response (abstr). Am J Hypertens 16 (2003) 161A
57. Rule A.D., Larson T.S., Bergstralh E.J., Slezak J.M., Jacobsen S.J., and Cosio F.G. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 141 (2004) 929-937
58. Perkins B.A., Nelson R.G., Ostrander B.E., et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol 16 (2005) 1404-1412
59. Mussap M., Dalla Vestra M., Fioretto P., et al. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 61 (2002) 1453-1461
60. Randers E., Erlandsen E.J., Pedersen O.L., Hasling C., and Danielsen H. Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function. Clin Nephrol 54 (2000) 203-209
61. Resnick H.E., and Foster G.L. Prevalence of elevated ankle-brachial index in the United States 1999 to 2002. Am J Med 118 (2005) 676-679